Laporan Laba Rugi (TTM)
Laporan Laba Rugi Comera Life Sciences Holdings, Inc. - Equity Warrant menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 12-31 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
| Change (%) | -27.79 | 2.35 | 23.16 | 36.50 | 15.04 | 47.00 | 18.09 | -8.97 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change (%) | 54.21 | 17.63 | -1.60 | 6.76 | 5.74 | 34.22 | 0.53 | -6.69 | |
| % of Revenue | 23.57 | 50.34 | 57.86 | 46.23 | 36.15 | 33.23 | 30.34 | 25.83 | 26.48 |
| Gross Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Change (%) | -53.08 | -13.14 | 57.14 | 62.07 | 20.31 | 53.37 | 25.73 | -9.77 | |
| % of Revenue | 76.43 | 49.66 | 42.14 | 53.77 | 63.85 | 66.77 | 69.66 | 74.17 | 73.52 |
| SG&A | 1 | 4 | 6 | 8 | 10 | 9 | 10 | 8 | 7 |
| Change (%) | 240.28 | 38.31 | 44.74 | 17.41 | -3.24 | 4.47 | -22.34 | -5.91 | |
| % of Revenue | 271.90 | 1,281.28 | 1,731.41 | 2,034.84 | 1,750.30 | 1,472.16 | 1,046.24 | 688.09 | 711.22 |
| R&D | 1 | 2 | 2 | 1 | 2 | 2 | 1 | 1 | 1 |
| Change (%) | 26.53 | 10.53 | -22.00 | 23.81 | -7.73 | -9.13 | -10.55 | -0.85 | |
| % of Revenue | 284.87 | 499.17 | 539.06 | 341.42 | 309.68 | 248.37 | 153.54 | 116.30 | 126.68 |
| OpEx | 3 | 6 | 8 | 10 | 12 | 11 | 11 | 9 | 9 |
| Change (%) | 127.80 | 30.17 | 28.14 | 18.11 | -3.75 | 3.11 | -20.30 | -5.23 | |
| % of Revenue | 580.34 | 1,830.79 | 2,328.33 | 2,422.48 | 2,096.13 | 1,753.76 | 1,230.12 | 830.22 | 864.38 |
| Operating Income | -2 | -6 | -7 | -9 | -11 | -10 | -11 | -8 | -8 |
| Change (%) | 160.19 | 31.77 | 28.36 | 17.32 | -4.69 | 0.46 | -23.70 | -4.71 | |
| % of Revenue | -480.34 | -1,730.79 | -2,228.33 | -2,322.48 | -1,996.13 | -1,653.77 | -1,130.12 | -730.22 | -764.38 |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | |||
| Change (%) | 16,488.31 | 59.64 | 36.98 | 14.24 | -21.10 | ||||
| % of Revenue | -0.02 | -2.32 | -3.22 | -3.00 | -2.90 | -2.52 | |||
| Net Income | -2 | -5 | -8 | -15 | -17 | -18 | -18 | -10 | -9 |
| Change (%) | 156.50 | 43.03 | 91.11 | 14.52 | 5.50 | -2.21 | -43.59 | -9.29 | |
| % of Revenue | -479.88 | -1,704.58 | -2,382.07 | -3,696.41 | -3,101.06 | -2,843.79 | -1,891.73 | -903.75 | -900.56 |
Source: Capital IQ
